Opendata, web and dolomites

PrevictDrugs SIGNED

Smartphone Measured Eye-Based Digital Biomarkers for Drug Use Detection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PrevictDrugs project word cloud

Explore the words cloud of the PrevictDrugs project. It provides you a very rough idea of what is the project "PrevictDrugs" about.

privacy    risks    cloud    tools    distance    instant    million    pupil    prioritisation    combine    worldwide    care    place    asked    pharmacodynamically    ab    internet    iot    correct    eyes    record    app    ai    suffering    unbound    biomarkers    time    gambling    disorders    interventions    device    communication    ing    nearly    innovative    proactive    relapse    settings    extreme    drug    cravings    personalised    sobriety    instantly    medical    patient    prepare    addictive    video    drugs    transform    previct    caregivers    treatments    fast    efficient    reactions    continuous    kontigo    ehealth    acceptance    thing    add    cameras    commercialisation    convenience    global    sophisticated    complete    outcomes    alcohol    reactive    monitoring    pupillometry    hazard    routes    smartphone    self    instead    market    efficiency    gaining    eye    illicit    personal    abuse    yield    screenings    designed    module    constitute    disruptive    voluntary    daily    solution    portal    clinical    therapy    platform    validating    digitalisation    patients    drive    suffer    mood    addiction    healthcare   

Project "PrevictDrugs" data sheet

The following table provides information about the project.

Coordinator
KONTIGO CARE AB 

Organization address
address: PAVEL SNICKARES GRAND 12
city: UPPSALA
postcode: 753 20
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2020-02-29

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KONTIGO CARE AB SE (UPPSALA) coordinator 50˙000.00

Map

 Project objective

Drug addiction is a global problem; nearly 30 million illicit drug users worldwide suffer from problematic drug use. Kontigo Care AB is developing an innovative medical device – Previct Drugs - a robust, app-based, eHealth-platform for place unbound, continuous, voluntary, self-monitoring of drug use. It will constitute an add-on to Kontigo Care’s current eHealth offer developed for management of other addictive disorders (alcohol abuse and hazard gambling). Using smartphone cameras, patients suffering from drug addiction, will be identified, and asked to record a 10 s long video of their eyes. Analysis of eye biomarkers associated with pharmacodynamically induced pupil reactions (pupillometry) will yield instant results on drug use/sobriety. Our unique, disruptive Internet of Thing (IoT)-based approach is designed to combine continuous monitoring of drug use and daily mood/cravings, with communication tools aimed at improving the impact of distance care. Real-time results become instantly available to caregivers through our cloud-based Care Portal, allowing fast interventions and correct patient prioritisation. This eHealth solution will drive healthcare digitalisation resulting in extreme cost-efficiency of out-patient treatments as well as convenience and complete privacy during drug screenings. A sophisticated AI-system will assess personal risks of relapse and transform addiction management to become proactive instead of reactive. This approach has the potential to enhance personalised therapy outcomes by ensuring that help can be provided fast to the patients who need it the most. The project objective is to prepare for commercialisation of the Previct Drugs module by determining the most efficient routes for gaining clinical and market acceptance by validating the product in clinical settings.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREVICTDRUGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREVICTDRUGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Plasmanorg (2019)

Environmental-friendly organic chemical synthesis in plasma reactor

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

ELDICO ED (2019)

ELDICO ED, Shaping the Future of Crystallography - The First Pure Electron Diffraction Equipment for Nano-Crystallography

Read More